Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bosmans

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|March 11, 2015
Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approachJulie K Klint, Jennifer J Smith, Irina Vetter, et al.
Toxins|June 26, 2019
Chemical Synthesis, Proper Folding, Na<sub>v</sub> Channel Selectivity Profile and Analgesic Properties of the Spider Peptide Phlotoxin 1Sébastien Nicolas, Claude Zoukimian, Frank Bosmans, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 30, 2016
Isolation of two insecticidal toxins from venom of the Australian theraphosid spider Coremiocnemis tropixMaria P Ikonomopoulou, Jennifer J Smith, Volker Herzig, et al.
Nature Communications|January 21, 2022
In vivo spatiotemporal control of voltage-gated ion channels by using photoactivatable peptidic toxinsJérôme Montnach, Laila Ananda Blömer, Ludivine Lopez, et al.
Npj Drug Discovery|June 8, 2026
Spider venom peptides Ht1a and Gg1a are toxic to honeybee parasite <i>Varroa destructor</i> by topical applicationVolker Herzig, Shaodong Guo, David A Eagles, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 13, 2025
Primary focal hyperhidrosis and autonomic symptom burden: a case-control study using the COMPASS-31 questionnaireAndrei Gurau, Wasay Nizam, Hamza Khan, et al.
JCI Insight|June 8, 2018
NaV1.1 inhibition can reduce visceral hypersensitivityJuan Salvatierra, Joel Castro, Andelain Erickson, et al.
Science (New York, N.Y.)|February 9, 2019
Structural basis of α-scorpion toxin action on Na<sub>v</sub> channelsThomas Clairfeuille, Alexander Cloake, Daniel T Infield, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 8, 2023
Anxiety and dysautonomia symptoms in patients with a Na<sub>V</sub>1.7 mutation and the potential benefits of low-dose short-acting guanfacineRita de Cássia Collaço, Maxime Lammens, Carley Blevins, et al.
JTCVS Open|March 10, 2025
Association of dysautonomia with refractory ventricular tachyarrhythmia in patients requiring thoracoscopic surgical cardiac sympathetic denervationAndrei Gurau, Dianela Perdomo, Hamza Khan, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|March 11, 2015
Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approachJulie K Klint, Jennifer J Smith, Irina Vetter, et al.
Toxins|June 26, 2019
Chemical Synthesis, Proper Folding, Na<sub>v</sub> Channel Selectivity Profile and Analgesic Properties of the Spider Peptide Phlotoxin 1Sébastien Nicolas, Claude Zoukimian, Frank Bosmans, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 30, 2016
Isolation of two insecticidal toxins from venom of the Australian theraphosid spider Coremiocnemis tropixMaria P Ikonomopoulou, Jennifer J Smith, Volker Herzig, et al.
Nature Communications|January 21, 2022
In vivo spatiotemporal control of voltage-gated ion channels by using photoactivatable peptidic toxinsJérôme Montnach, Laila Ananda Blömer, Ludivine Lopez, et al.
Npj Drug Discovery|June 8, 2026
Spider venom peptides Ht1a and Gg1a are toxic to honeybee parasite <i>Varroa destructor</i> by topical applicationVolker Herzig, Shaodong Guo, David A Eagles, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 13, 2025
Primary focal hyperhidrosis and autonomic symptom burden: a case-control study using the COMPASS-31 questionnaireAndrei Gurau, Wasay Nizam, Hamza Khan, et al.
JCI Insight|June 8, 2018
NaV1.1 inhibition can reduce visceral hypersensitivityJuan Salvatierra, Joel Castro, Andelain Erickson, et al.
Science (New York, N.Y.)|February 9, 2019
Structural basis of α-scorpion toxin action on Na<sub>v</sub> channelsThomas Clairfeuille, Alexander Cloake, Daniel T Infield, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 8, 2023
Anxiety and dysautonomia symptoms in patients with a Na<sub>V</sub>1.7 mutation and the potential benefits of low-dose short-acting guanfacineRita de Cássia Collaço, Maxime Lammens, Carley Blevins, et al.
JTCVS Open|March 10, 2025
Association of dysautonomia with refractory ventricular tachyarrhythmia in patients requiring thoracoscopic surgical cardiac sympathetic denervationAndrei Gurau, Dianela Perdomo, Hamza Khan, et al.
Pageof 9